ATN-161 as an integrin α5β1 antagonist depresses ocular neovascularization by promoting new vascular endothelial cell apoptosis

Ailing Sui, Yisheng Zhong, Anna M. Demetriades, Jikui Shen, Ting Su, Yiyun Yao, Yushuo Gao, Yanji Zhu, Xi Shen, Bing Xie

Research output: Contribution to journalArticle

Abstract

Background: ATN-161 (Ac-PHSCN-NH2), an antagonist of integrin α5β1, has shown an important influence in inhibiting tumor angiogenesis and metastasis of other tumor types. However, the mechanism of action of ATN-161 and whether it can inhibit ocular neovascularization (NV) are unclear. This study investigated the role of ATN-161 in regulating ocular angiogenesis in mouse models and explored the underlying signaling pathway. Material/Methods: An oxygen-induced retinopathy (OIR) mouse model and a laser-induced choroidal neovascularization (CNV) mouse model were used to test integrin α5β1 expression and the effect of ATN-161 on ocular NV by immunofluorescence staining, Western blot analysis, and flat-mount analysis. The activation of nuclear factor-κB (NF-κB), matrix metalloproteinase-2/9 (MMP-2/9), and cell apoptosis were detected by immunofluorescence staining, Western blot, real-time RT-PCR, and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL). The cell proliferation was detected by BrdU labeling. Results: In OIR and CNV mice, the protein expression level of integrin α5β1 increased compared with that in age-matched controls. The mice given ATN-161 had significantly reduced retinal neovascularization (RNV) and CNV. Blocking integrin α5β1 by ATN-161 strongly inhibited nuclear factor-κB (NF-κB) activation and matrix metalloproteinase-2/9 (MMP-2/9) expression and promoted cell apoptosis, but the effect of ATN-161 on proliferation in CNV mice was indirect and required the inhibition of neovascularization. Inhibiting NF-κB activation by ammonium pyrrolidinedithiocarbamate (PDTC) reduced RNV and promoted cell apoptosis in ocular NV. Conclusions: Blocking integrin α5β1 by ATN-161 reduced ocular NV by inhibiting MMP-2/MMP-9 expression and promoting the cell apoptosis of ocular NV.

Original languageEnglish (US)
Pages (from-to)5860-5873
Number of pages14
JournalMedical Science Monitor
Volume24
DOIs
StatePublished - Aug 22 2018

Fingerprint

Integrins
Choroidal Neovascularization
Endothelial Cells
Apoptosis
Retinal Neovascularization
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Matrix Metalloproteinases
Fluorescent Antibody Technique
Western Blotting
Staining and Labeling
Oxygen
DNA Nucleotidylexotransferase
Bromodeoxyuridine
Ammonium Compounds
Real-Time Polymerase Chain Reaction
Neoplasms
Lasers
Cell Proliferation
Neoplasm Metastasis

Keywords

  • Apoptosis
  • Integrin alpha5beta1
  • Matrix metalloproteinases
  • Neovascularization, Pathologic
  • NF-kappa B

ASJC Scopus subject areas

  • Medicine(all)

Cite this

ATN-161 as an integrin α5β1 antagonist depresses ocular neovascularization by promoting new vascular endothelial cell apoptosis. / Sui, Ailing; Zhong, Yisheng; Demetriades, Anna M.; Shen, Jikui; Su, Ting; Yao, Yiyun; Gao, Yushuo; Zhu, Yanji; Shen, Xi; Xie, Bing.

In: Medical Science Monitor, Vol. 24, 22.08.2018, p. 5860-5873.

Research output: Contribution to journalArticle

Sui, Ailing ; Zhong, Yisheng ; Demetriades, Anna M. ; Shen, Jikui ; Su, Ting ; Yao, Yiyun ; Gao, Yushuo ; Zhu, Yanji ; Shen, Xi ; Xie, Bing. / ATN-161 as an integrin α5β1 antagonist depresses ocular neovascularization by promoting new vascular endothelial cell apoptosis. In: Medical Science Monitor. 2018 ; Vol. 24. pp. 5860-5873.
@article{25e957fdaef94e58a308e25f3dbb731f,
title = "ATN-161 as an integrin α5β1 antagonist depresses ocular neovascularization by promoting new vascular endothelial cell apoptosis",
abstract = "Background: ATN-161 (Ac-PHSCN-NH2), an antagonist of integrin α5β1, has shown an important influence in inhibiting tumor angiogenesis and metastasis of other tumor types. However, the mechanism of action of ATN-161 and whether it can inhibit ocular neovascularization (NV) are unclear. This study investigated the role of ATN-161 in regulating ocular angiogenesis in mouse models and explored the underlying signaling pathway. Material/Methods: An oxygen-induced retinopathy (OIR) mouse model and a laser-induced choroidal neovascularization (CNV) mouse model were used to test integrin α5β1 expression and the effect of ATN-161 on ocular NV by immunofluorescence staining, Western blot analysis, and flat-mount analysis. The activation of nuclear factor-κB (NF-κB), matrix metalloproteinase-2/9 (MMP-2/9), and cell apoptosis were detected by immunofluorescence staining, Western blot, real-time RT-PCR, and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL). The cell proliferation was detected by BrdU labeling. Results: In OIR and CNV mice, the protein expression level of integrin α5β1 increased compared with that in age-matched controls. The mice given ATN-161 had significantly reduced retinal neovascularization (RNV) and CNV. Blocking integrin α5β1 by ATN-161 strongly inhibited nuclear factor-κB (NF-κB) activation and matrix metalloproteinase-2/9 (MMP-2/9) expression and promoted cell apoptosis, but the effect of ATN-161 on proliferation in CNV mice was indirect and required the inhibition of neovascularization. Inhibiting NF-κB activation by ammonium pyrrolidinedithiocarbamate (PDTC) reduced RNV and promoted cell apoptosis in ocular NV. Conclusions: Blocking integrin α5β1 by ATN-161 reduced ocular NV by inhibiting MMP-2/MMP-9 expression and promoting the cell apoptosis of ocular NV.",
keywords = "Apoptosis, Integrin alpha5beta1, Matrix metalloproteinases, Neovascularization, Pathologic, NF-kappa B",
author = "Ailing Sui and Yisheng Zhong and Demetriades, {Anna M.} and Jikui Shen and Ting Su and Yiyun Yao and Yushuo Gao and Yanji Zhu and Xi Shen and Bing Xie",
year = "2018",
month = "8",
day = "22",
doi = "10.12659/MSM.907446",
language = "English (US)",
volume = "24",
pages = "5860--5873",
journal = "Medical Science Monitor",
issn = "1234-1010",
publisher = "International Scientific Literature Inc.",

}

TY - JOUR

T1 - ATN-161 as an integrin α5β1 antagonist depresses ocular neovascularization by promoting new vascular endothelial cell apoptosis

AU - Sui, Ailing

AU - Zhong, Yisheng

AU - Demetriades, Anna M.

AU - Shen, Jikui

AU - Su, Ting

AU - Yao, Yiyun

AU - Gao, Yushuo

AU - Zhu, Yanji

AU - Shen, Xi

AU - Xie, Bing

PY - 2018/8/22

Y1 - 2018/8/22

N2 - Background: ATN-161 (Ac-PHSCN-NH2), an antagonist of integrin α5β1, has shown an important influence in inhibiting tumor angiogenesis and metastasis of other tumor types. However, the mechanism of action of ATN-161 and whether it can inhibit ocular neovascularization (NV) are unclear. This study investigated the role of ATN-161 in regulating ocular angiogenesis in mouse models and explored the underlying signaling pathway. Material/Methods: An oxygen-induced retinopathy (OIR) mouse model and a laser-induced choroidal neovascularization (CNV) mouse model were used to test integrin α5β1 expression and the effect of ATN-161 on ocular NV by immunofluorescence staining, Western blot analysis, and flat-mount analysis. The activation of nuclear factor-κB (NF-κB), matrix metalloproteinase-2/9 (MMP-2/9), and cell apoptosis were detected by immunofluorescence staining, Western blot, real-time RT-PCR, and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL). The cell proliferation was detected by BrdU labeling. Results: In OIR and CNV mice, the protein expression level of integrin α5β1 increased compared with that in age-matched controls. The mice given ATN-161 had significantly reduced retinal neovascularization (RNV) and CNV. Blocking integrin α5β1 by ATN-161 strongly inhibited nuclear factor-κB (NF-κB) activation and matrix metalloproteinase-2/9 (MMP-2/9) expression and promoted cell apoptosis, but the effect of ATN-161 on proliferation in CNV mice was indirect and required the inhibition of neovascularization. Inhibiting NF-κB activation by ammonium pyrrolidinedithiocarbamate (PDTC) reduced RNV and promoted cell apoptosis in ocular NV. Conclusions: Blocking integrin α5β1 by ATN-161 reduced ocular NV by inhibiting MMP-2/MMP-9 expression and promoting the cell apoptosis of ocular NV.

AB - Background: ATN-161 (Ac-PHSCN-NH2), an antagonist of integrin α5β1, has shown an important influence in inhibiting tumor angiogenesis and metastasis of other tumor types. However, the mechanism of action of ATN-161 and whether it can inhibit ocular neovascularization (NV) are unclear. This study investigated the role of ATN-161 in regulating ocular angiogenesis in mouse models and explored the underlying signaling pathway. Material/Methods: An oxygen-induced retinopathy (OIR) mouse model and a laser-induced choroidal neovascularization (CNV) mouse model were used to test integrin α5β1 expression and the effect of ATN-161 on ocular NV by immunofluorescence staining, Western blot analysis, and flat-mount analysis. The activation of nuclear factor-κB (NF-κB), matrix metalloproteinase-2/9 (MMP-2/9), and cell apoptosis were detected by immunofluorescence staining, Western blot, real-time RT-PCR, and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL). The cell proliferation was detected by BrdU labeling. Results: In OIR and CNV mice, the protein expression level of integrin α5β1 increased compared with that in age-matched controls. The mice given ATN-161 had significantly reduced retinal neovascularization (RNV) and CNV. Blocking integrin α5β1 by ATN-161 strongly inhibited nuclear factor-κB (NF-κB) activation and matrix metalloproteinase-2/9 (MMP-2/9) expression and promoted cell apoptosis, but the effect of ATN-161 on proliferation in CNV mice was indirect and required the inhibition of neovascularization. Inhibiting NF-κB activation by ammonium pyrrolidinedithiocarbamate (PDTC) reduced RNV and promoted cell apoptosis in ocular NV. Conclusions: Blocking integrin α5β1 by ATN-161 reduced ocular NV by inhibiting MMP-2/MMP-9 expression and promoting the cell apoptosis of ocular NV.

KW - Apoptosis

KW - Integrin alpha5beta1

KW - Matrix metalloproteinases

KW - Neovascularization, Pathologic

KW - NF-kappa B

UR - http://www.scopus.com/inward/record.url?scp=85053696324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053696324&partnerID=8YFLogxK

U2 - 10.12659/MSM.907446

DO - 10.12659/MSM.907446

M3 - Article

C2 - 30133427

AN - SCOPUS:85053696324

VL - 24

SP - 5860

EP - 5873

JO - Medical Science Monitor

JF - Medical Science Monitor

SN - 1234-1010

ER -